Quality & Patient Safety

U.S. investigators: Contaminated heparin is global problem

Patient Safety Monitor: Global Edition, April 29, 2008

Investigators in the United States found that not only has contaminated blood thinner heparin caused dozens of U.S. deaths, but that it has affected 10 other countries, reports the L.A. Times.

Chinese officials doubt the claim that contamination occurred in the early stages of the drug's production on farms in China and urged for an inspection of Baxter Healthcare, a U.S. company that distributes heparin in the U.S., according to the Times.

The contaminant causes symptoms similar to allergic reactions. Imports of the drug from China have been banned in the U.S., reports the Times.

To read more, click here.

Comments

0 comments on “U.S. investigators: Contaminated heparin is global problem

 

    Patient Safety Monitor
  • Patient Safety Monitor

    As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...

  • Patient Safety Monitor Alert

    This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...

  • Patient Safety Quality Monthly

    Ken Rohde, Senior Consultant for The Greeley Company with over 25 years of experience in quality management. His roles in...

  • Occurrence Reporting:

    Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...

Most Popular

Related Articles